National Health Investors, Inc.: 10-K filed 2012-02-15
What National Health Investors, Inc. reported in its annual report filed 2012-02-15 (fiscal FY 2011): 21 published measures, 108 facts as tagged in accession 0000877860-12-000005.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-02-15
- Fiscal period
- fiscal FY 2011
- Accession
- 0000877860-12-000005 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All National Health Investors, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 579,563,000 | USD | |
| At 2010-12-31 | 509,341,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 136,078,000 | USD | |
| At 2010-12-31 | 66,841,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 15,886,000 | USD | |
| At 2010-12-31 | 2,664,000 | USD | |
| At 2009-12-31 | 45,718,000 | USD | |
| At 2008-12-31 | 100,242,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 18,114,000 | USD | 92 |
| 2011-01-01 to 2011-12-31 | 81,132,000 | USD | 365 |
| 2011-07-01 to 2011-09-30 | 18,808,000 | USD | 92 |
| 2011-04-01 to 2011-06-30 | 25,117,000 | USD | 91 |
| 2011-01-01 to 2011-03-31 | 19,093,000 | USD | 90 |
| 2010-10-01 to 2010-12-31 | 16,954,000 | USD | 92 |
| 2010-01-01 to 2010-12-31 | 69,421,000 | USD | 365 |
| 2010-07-01 to 2010-09-30 | 17,334,000 | USD | 92 |
| 2010-04-01 to 2010-06-30 | 19,189,000 | USD | 91 |
| 2010-01-01 to 2010-03-31 | 15,944,000 | USD | 90 |
| 2009-01-01 to 2009-12-31 | 64,229,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 76,854,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 77,544,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 69,062,000 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 21,524,000 | USD | 92 |
| 2011-01-01 to 2011-12-31 | 82,702,000 | USD | 365 |
| 2011-07-01 to 2011-09-30 | 20,454,000 | USD | 92 |
| 2011-04-01 to 2011-06-30 | 20,199,000 | USD | 91 |
| 2011-01-01 to 2011-03-31 | 20,525,000 | USD | 90 |
| 2010-10-01 to 2010-12-31 | 19,510,000 | USD | 92 |
| 2010-01-01 to 2010-12-31 | 78,032,000 | USD | 365 |
| 2010-07-01 to 2010-09-30 | 19,419,000 | USD | 92 |
| 2010-04-01 to 2010-06-30 | 19,011,000 | USD | 91 |
| 2010-01-01 to 2010-03-31 | 20,092,000 | USD | 90 |
| 2009-01-01 to 2009-12-31 | 62,793,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -8,158,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -28,569,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -68,458,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -55,474,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -92,029,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -55,128,000 | USD | 365 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 27,741,961 | shares | 92 |
| 2011-01-01 to 2011-12-31 | 27,719,096 | shares | 365 |
| 2011-07-01 to 2011-09-30 | 27,729,560 | shares | 92 |
| 2011-04-01 to 2011-06-30 | 27,708,136 | shares | 91 |
| 2011-01-01 to 2011-03-31 | 27,696,727 | shares | 90 |
| 2010-10-01 to 2010-12-31 | 27,686,217 | shares | 92 |
| 2010-01-01 to 2010-12-31 | 27,664,482 | shares | 365 |
| 2010-07-01 to 2010-09-30 | 27,673,703 | shares | 92 |
| 2010-04-01 to 2010-06-30 | 27,665,629 | shares | 91 |
| 2010-01-01 to 2010-03-31 | 27,632,376 | shares | 90 |
| 2009-01-01 to 2009-12-31 | 27,586,338 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 27,784,915 | shares | 92 |
| 2011-01-01 to 2011-12-31 | 27,792,592 | shares | 365 |
| 2011-07-01 to 2011-09-30 | 27,789,725 | shares | 92 |
| 2011-04-01 to 2011-06-30 | 27,799,616 | shares | 91 |
| 2011-01-01 to 2011-03-31 | 27,796,109 | shares | 90 |
| 2010-10-01 to 2010-12-31 | 27,783,517 | shares | 92 |
| 2010-01-01 to 2010-12-31 | 27,732,959 | shares | 365 |
| 2010-07-01 to 2010-09-30 | 27,737,802 | shares | 92 |
| 2010-04-01 to 2010-06-30 | 27,729,034 | shares | 91 |
| 2010-01-01 to 2010-03-31 | 27,681,479 | shares | 90 |
| 2009-01-01 to 2009-12-31 | 27,618,300 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 0.65 | USD/shares | 92 |
| 2011-01-01 to 2011-12-31 | 2.93 | USD/shares | 365 |
| 2011-07-01 to 2011-09-30 | 0.68 | USD/shares | 92 |
| 2011-04-01 to 2011-06-30 | 0.91 | USD/shares | 91 |
| 2011-01-01 to 2011-03-31 | 0.69 | USD/shares | 90 |
| 2010-10-01 to 2010-12-31 | 0.61 | USD/shares | 92 |
| 2010-01-01 to 2010-12-31 | 2.51 | USD/shares | 365 |
| 2010-07-01 to 2010-09-30 | 0.62 | USD/shares | 92 |
| 2010-04-01 to 2010-06-30 | 0.69 | USD/shares | 91 |
| 2010-01-01 to 2010-03-31 | 0.58 | USD/shares | 90 |
| 2009-01-01 to 2009-12-31 | 2.33 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-10-01 to 2011-12-31 | 0.65 | USD/shares | 92 |
| 2011-01-01 to 2011-12-31 | 2.92 | USD/shares | 365 |
| 2011-07-01 to 2011-09-30 | 0.68 | USD/shares | 92 |
| 2011-04-01 to 2011-06-30 | 0.9 | USD/shares | 91 |
| 2011-01-01 to 2011-03-31 | 0.69 | USD/shares | 90 |
| 2010-10-01 to 2010-12-31 | 0.61 | USD/shares | 92 |
| 2010-01-01 to 2010-12-31 | 2.5 | USD/shares | 365 |
| 2010-07-01 to 2010-09-30 | 0.62 | USD/shares | 92 |
| 2010-04-01 to 2010-06-30 | 0.69 | USD/shares | 91 |
| 2010-01-01 to 2010-03-31 | 0.58 | USD/shares | 90 |
| 2009-01-01 to 2009-12-31 | 2.32 | USD/shares | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 61,864,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 58,201,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 48,655,000 | USD | 365 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 2,070,000 | USD | 365 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 20,838,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 19,831,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 14,138,000 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 27,751,208 | shares | |
| At 2010-12-31 | 27,689,392 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 443,485,000 | USD | |
| At 2010-12-31 | 442,500,000 | USD | |
| At 2009-12-31 | 434,612,000 | USD | |
| At 2008-12-31 | 429,615,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 72,983,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 70,648,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 67,544,000 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 7,473,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 7,696,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 5,255,000 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 596,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 566,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 269,000 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 713,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 73,000 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -174,000 | USD | 365 |
Inspect the source
- Entity
- National Health Investors, Inc. / CIK 0000877860
- Captured
- 2026-09-20T05:01:19.323Z
- SEC response SHA-256
800d4eb06d8d005c13461b54ffacc4cde98eabd76680f56a43c825e171984500
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000877860.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))